【レポートの概要（一部）】
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 05: MARKET SIZING
• Market definition
• Market sizing 2017
• Market size and forecast 2017-2022
PART 06: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 07: MARKET SEGMENTATION BY INDICATION
• Segmentation by indication
• Comparison by indication
• MD drugs
• DED drugs
• Others
• Market opportunity by indication
PART 08: MARKET SEGMENTATION BY DRUG CLASS
• Segmentation by drug class
• Anti-VEGF agents
• Corticosteroids
• Others
PART 09: CUSTOMER LANDSCAPE
PART 10: REGIONAL LANDSCAPE
• Geographical segmentation
• Regional comparison
• Retinal drugs market in Americas
• Retinal drugs market in EMEA
• Retinal drugs market in APAC
• Market opportunity
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 13: MARKET TRENDS
• Development of innovative therapies
• Rise in demand for sustained-release ocular formulations
PART 14: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 15: VENDOR ANALYSIS0
• Vendors covered
• Vendor classification
• Market positioning of vendors
• ALLERGAN
• Bayer
• F. Hoffmann-La Roche
• Novartis
• Regeneron Pharmaceuticals
• Valeant Pharmaceuticals
PART 16: APPENDIX
• List of abbreviations
• Exhibit 01: Parent market
• Exhibit 02: Global ophthalmic drugs market segmentation
• Exhibit 03: Market characteristics
• Exhibit 04: Market segments
• Exhibit 05: Market definition – Inclusions and exclusions checklist
• Exhibit 06: Market size 2017
• Exhibit 07: Validation techniques employed for market sizing 2017
• Exhibit 08: Global retinal drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 09: Global retinal drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 10: Five forces analysis 2017
• Exhibit 11: Five forces analysis 2022
• Exhibit 12: Bargaining power of buyers
• Exhibit 13: Bargaining power of suppliers
• Exhibit 14: Threat of new entrants
• Exhibit 15: Threat of substitutes
• Exhibit 16: Threat of rivalry
• Exhibit 17: Market condition – Five forces 2017
• Exhibit 18: Global retinal drugs market – Market share by indication 2017-2022 (%)
• Exhibit 19: Comparison by indication
• Exhibit 20: Global MD drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 21: Global MD drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 22: Global DED drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 23: Global DED drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 24: Global other retinal diseases drugs market – Market size and forecast 2017-2022 ($ mn)
• Exhibit 25: Global other retinal diseases drugs market – Year-over-year growth 2018-2022 (%)
• Exhibit 26: Market opportunity by indication
• Exhibit 27: Global retinal drugs market share by drug class 2017 (%)
• Exhibit 28: Major anti-VEGF agents approved in the market
• Exhibit 29: Major corticosteroids approved in the market
• Exhibit 30: Customer landscape
• Exhibit 31: Global retinal drugs market – Market share by geography 2017-2022 (%)
• Exhibit 32: Regional comparison
• Exhibit 33: Retinal drugs market in Americas – Market size and forecast 2017-2022 ($ mn)
• Exhibit 34: Retinal drugs market in Americas – Year-over-year growth 2018-2022 (%)
• Exhibit 35: Top 3 countries in Americas
• Exhibit 36: Retinal drugs market in EMEA – Market size and forecast 2017-2022 ($ mn)
• Exhibit 37: Retinal drugs market in EMEA – Year-over-year growth 2018-2022 (%)
• Exhibit 38: Top 3 countries in EMEA
• Exhibit 39: Retinal drugs market in APAC – Market size and forecast 2017-2022 ($ mn)
• Exhibit 40: Retinal drugs market in APAC – Year-over-year growth 2018-2022 (%)
• Exhibit 41: Top 3 countries in APAC
• Exhibit 42: Market opportunity
• Exhibit 43: Vendor landscape
• Exhibit 44: Landscape disruption
• Exhibit 45: Vendors covered
• Exhibit 46: Vendor classification
• Exhibit 47: Market positioning of vendors
• Exhibit 48: ALLERGAN – Overview
• Exhibit 49: ALLERGAN – Business segments
• Exhibit 50: ALLERGAN – Organizational developments
• Exhibit 51: ALLERGAN – Geographic focus
• Exhibit 52: ALLERGAN – Segment focus
• Exhibit 53: ALLERGAN – Key offering
• Exhibit 54: ALLERGAN – Key customers
• Exhibit 55: Bayer – Overview
• Exhibit 56: Bayer – Business segments
• Exhibit 57: Bayer – Organizational developments
• Exhibit 58: Bayer – Geographic focus
• Exhibit 59: Bayer – Segment focus
• Exhibit 60: Bayer – Key offerings
• Exhibit 61: Bayer – Key customers
• Exhibit 62: F. Hoffmann-La Roche – Overview
• Exhibit 63: F. Hoffmann-La Roche – Business segments
• Exhibit 64: F. Hoffmann-La Roche – Organizational developments
• Exhibit 65: F. Hoffmann-La Roche – Geographic focus
• Exhibit 66: F. Hoffmann-La Roche – Segment focus
• Exhibit 67: F. Hoffmann-La Roche – Key offerings
• Exhibit 68: F. Hoffmann-La Roche – Key customers
• Exhibit 69: Novartis – Overview
• Exhibit 70: Novartis – Business segments
• Exhibit 71: Novartis – Organizational developments
• Exhibit 72: Novartis – Geographic focus
• Exhibit 73: Novartis – Segment focus
• Exhibit 74: Novartis – Key offerings
• Exhibit 75: Novartis – Key customers
• Exhibit 76: Regeneron Pharmaceuticals – Overview
• Exhibit 77: Regeneron Pharmaceuticals – Business segments
• Exhibit 78: Regeneron Pharmaceuticals – Organizational developments
• Exhibit 79: Regeneron Pharmaceuticals – Geographic focus
• Exhibit 80: Regeneron Pharmaceuticals – Segment focus
• Exhibit 81: Regeneron Pharmaceuticals – Key offerings
• Exhibit 82: Regeneron Pharmaceuticals – Key customers
• Exhibit 83: Valeant Pharmaceuticals – Overview
• Exhibit 84: Valeant Pharmaceuticals – Business segments
• Exhibit 85: Valeant Pharmaceuticals – Organizational developments
• Exhibit 86: Valeant Pharmaceuticals – Geographic focus
• Exhibit 87: Valeant Pharmaceuticals – Segment focus
• Exhibit 88: Valeant Pharmaceuticals – Key offerings
• Exhibit 89: Valeant Pharmaceuticals – Key customers
【レポート販売概要】
■ タイトル：網膜用治療薬の世界市場2018-2022■ 英文：Global Retinal Drugs Market 2018-2022
■ 発行日：2018年4月16日
■ 調査会社：Technavio
■ 商品コード：IRTNTR22469
■ 調査対象地域：グローバル
- 2014年戦略提言：ドイツの病院血液及びフローサイトメトリー市場This new report from Venture Planning Group contains 233 pages, 15 tables, and presents a comprehensive analysis of the German hospital hematology and flow cytometry markets, including: Major issues pertaining to the German hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next te …
- スポーツウェア・フィットネスウェアの世界市場2016-2020About Sports and Fitness Wear Sports and fitness wear is worn during workouts, sports, or any physical exercise to provide the wearer comfort and style. T-shirts, hoodies, shorts, and tracksuits are typical sport-specific apparel used while playing sports and doing other physical activities such as exercise. Sports and fitness apparel is designed to be lightweight and has thermal properties that a …
- ヨーロッパの顕微鏡市場About Microscope A microscope is used to observe objects that are too small to be seen with a naked eye. Microscopes can be used to see fine structures in a sample as they offer a magnified image. The science of investigating small or tiny objects using such an instrument is called microscopy. Microscopy devices are known to provide knowledge about biological processes at a cellular level. Technav …
- 欧州の授乳用品市場2016-2020About the Breastfeeding Supplies Market in Europe Breastfeeding supplies are used to assist lactating mothers to express and store milk for later use. Most breastfeeding supplies permit a direct expression of pumped breast milk into a bottle, which can be stored for later use. These supplies may also be used to stimulate lactation in mothers who have an irregular milk flow. Technavio’s analysts fo …
- 企業向けアプリケーション市場：技術及び市場動向Summary Enterprise applications continue to form the backbone of most organizations' enterprise infrastructure. Enterprise applications have come a long way, from being an on-premise standalone solution to becoming mobility and cloud computing enabled enterprise applications that are often closely integrated with other business applications. Furthermore, global customers and the need for widesprea …
- 滅菌サービスの世界市場予測（～2022年）：蒸気滅菌、エチレンオキシド滅菌、ガンマ線滅菌、電子線滅菌The global sterilization services market is projected to reach USD 3.31 Billion by 2022 at a CAGR of 6.7% during the forecast period. The growth of the market can be attributed to the increasing focus on outsourcing of sterilization processes among pharmaceutical companies, hospitals, and medical device manufacturers; increasing prevalence of hospital-acquired infections; growth in the number of s …
- ガスケット及びシールの世界市場2016-2020About Gasket and Seals Seals and gaskets play a vital role in any assembly process. These components are widely used to fit two mating surfaces to prevent leakage. - Seals A seal is used to control leakage of liquids or gases in the automotive, manufacturing, aerospace, electrical and electronics and petrochemical industries. Seals help in reducing problems associated with pollution due to leakage …
- 2014年戦略提言：ヨーロッパの腫瘍マーカー検査市場This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test.This comprehensive five-country report identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends in France, Germany, Italy, Spain, and the UK; reviews current and emergin …
- 血栓管理装置の世界市場分析：製品別（神経血管塞栓摘出装置、塞栓摘出バルーンカテーテル、経皮的血栓摘出装置、カテーテル指向性血栓溶解装置）、エンドユーザー別、セグメント予測、2013 – 2024The global clot management market was valued at USD 1.26 billion in 2015 and is further expected to reach a value of USD 1.88 billion by 2024, according to a new report by Grand View Research, Inc. The market is expected to grow with a CAGR of 4.6% owing to the key drivers such as increasing prevalence of stroke, Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), obesity, growing geriatric popul …
- Duodopa (パーキンソン病)：医薬品市場予測及び分析（～2022）Duodopa (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. D …
- 肝機能不全(Hepatic Insufficiency)：世界の治験レビュー（2015年上半期版）Hepatic Insufficiency Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatic Insufficiency Global Clinical Trials Review, H1, 2015" provides data on the Hepatic Insufficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatic Insufficiency. It includes an overview of the trial numbers and the …
- 世界の定量ポンプ市場調査：Global Metering Pump Market 2014-2018TechNavio's analysts forecast the Global Metering Pump market to grow at a CAGR of 4.04 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for safe drinking water. The Global Metering Pump market has also been witnessing the increasing popularity of digital pumping solutions. However, the increasing price wars among vendors could p …
- 血行力学的モニタリング装置の世界市場予測（～2021）The global hemodynamic monitoring systems market is expected to reach USD 1,143.7 Million by 2021 from USD 925.2 Million in 2016, growing at a CAGR of 4.3% from 2016 to 2021. The global hemodynamic monitoring systems market has been segmented on the basis of product, type, end user, and region. By product, the market is segmented into systems and disposables. The disposables segment is expected to …
- ベビー用ファッション・アクセサリーの世界市場2016-2020About the Baby Fashion Accessories Market In 2015, the clothing accessories segment led the global baby fashion accessories market. Vendors like Gap, Ralph Lauren, and Carter’s have a range of product lines for clothing accessories. Product innovation is one of the most important factors considered by retailers to set competitive advantage. Multifunctional clothing accessories have become a major …
- スペインの心臓人工弁市場見通し（～2021）Spain Prosthetic Heart Valve Procedures Outlook to 2021 Summary GlobalData’s new report, "Spain Prosthetic Heart Valve Procedures Outlook to 2021", provides key procedures data on the Spain Prosthetic Heart Valve Procedures. The report provides procedure volumes within market segments - Conventional Aortic Valve Replacement Procedures, Conventional Mitral Valve Procedures and Transcatheter Heart V …
